CATEGORIES

Press Release

LATEST

TRENDING

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Claims Conference Secures $13.5 Million In Funding To Get Holocaust Survivors To Vaccine Sites

A New Program, Established by The Claims Conference and Funded by The German Government, Will Ensure Holocaust Survivors Globally Have the Means to Get To COVID-19 Vaccine Sites

First “Global State of Digital Health Report” Tapping into 200 Million Data Points Examines More Than 12,000 Digital Health Ventures Now Available

Breaking Digital Health Report Will Guide C-Suite Entrepreneurs and Private Equity Investment Strategies

Digital Salutem Welcomes Gil Bashe and Stacy Hurt as Board Members

Digital Salutem is delighted to announce that digital health influencers, Gil Bashe and Stacy Hurt, have joined ours team as board members